Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...

Market Research Report Highlights Key Trends, Drivers, and InnovationsThe DNA sequencing market has emerged as a cornerstone ...

Details: Two FFPE-derived DNA samples (colon and liver) alongside a high-quality genomic DNA control (NA12878) were used to ...

This study demonstrates that NGS-MSI is noninferior to IHC-MMR and can identify MSI-H tumors that IHC-MMR is unable to detect and conversely IHC-MMR can identify MMRd tumors that NGS-MSI misses. This ...

The market presents significant opportunities in companion diagnostics for personalized medicine and point-of-care testing ...

The table shows the representative samples and their associated read counts. AutoNormalization effectively normalized the ...

The convergence of biomarker-driven testing, AI-enabled diagnostics, and pharma-diagnostics partnerships are transforming how treatments are developed, prescribed, and delivered worldwide. NEW ...

The CDx System is a combination medical device consisting of the OncoGuide™ OncoScreen™ Plus CDx Kit and the OncoGuide™ ...

Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million Department of Defense (DoD) contract to deploy ANTIDOTE, a pioneering biosecurity platform capable of ...

The Fund had a strong second quarter, outperforming its benchmarks, the Russell 1000 Growth Index and the S&P 500 Index. Read ...